Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Astellas launches $3.5 billion hostile bid for OSI

Mar 01 2010

• By Simon Varcoe

Related Companies

OSI Systems, Inc.

Genentech, Inc.

Astellas Pharma, Inc.

Additional Topics

Deals Metabolic Disorders Cancer

More from Alimentary/Metabolic

More from Therapeutic Category

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window